Home – We R.A. Priority

We R.A. Priority is a disease awareness programme that has been developed and paid for by Gilead Sciences Ltd, a science-based pharmaceutical company with support from The National Rheumatoid Arthritis Society (NRAS).

Privacy Policy

Over 400,000 people across the UK live with
the daily reality of Rheumatoid Arthritis (RA).¹

This irreversible

can cause daily pain, anxiety and cause people to feel isolated and alone.

This irreversible

can cause daily pain, anxiety and cause people to feel isolated and alone.

Yet, RA is still misunderstood. It is time to change perceptions. RA can affect anyone of any age. RA can strike at any time. RA can be with you for life.

By coming together, we can show how important understanding RA is. We can show society that We R.A. Priority.

Show your support for the RA community.

You are now leaving www.werapriority.co.uk and visiting a new site which is now owned or controlled by Gilead Sciences.

Gilead Sciences is therefore not responsible for your interactions with the website or the information it provides

Cancel

Visit NRAS to learn
more about living with RA:

supporters

to add your
support to the
RA community

Cancel

The We R.A. Priority campaign features real people living with rheumatoid arthritis in the U.K.

This campaign is supported by

Cookie Policy

We R.A. Priority is a disease awareness programme that has been developed and paid for by Gilead Sciences Ltd, a science-based pharmaceutical company with support from The National Rheumatoid Arthritis Society (NRAS).

Document number: UK-INF-2020-07-0006

Date of preparation: October 2020

Gilead and the Gilead logo are trademarks of Gilead Sciences, Inc.

¹NHS. Arthritis. Available at: https://bit.ly/2sXWn6j. Last accessed: October 2020